UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 2.708

Sortiert nach

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles

Oncogene, 2019-03, Vol.38 (13), p.2380-2393

2019

Volltextzugriff (PDF)

Diagnosis and Treatment of Ovarian Cancer

Hematology/oncology clinics of North America, 2018-12, Vol.32 (6), p.943-964

2018

Volltextzugriff (PDF)

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells

Blood, 2011-11, Vol.118 (20), p.5498-5505

2011

Volltextzugriff (PDF)

MRI-Guided High–Dose-Rate Intracavitary Brachytherapy for Treatment of Cervical Cancer: The University of Pittsburgh Experience

International journal of radiation oncology, biology, physics, 2015-03, Vol.91 (3), p.540-547

2015

Volltextzugriff (PDF)

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells

Cell reports (Cambridge), 2017-10, Vol.21 (1), p.154-167

2017

Volltextzugriff (PDF)

Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer

Clinical cancer research, 2013-03, Vol.19 (5), p.1213-1224

2013

Volltextzugriff (PDF)

Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer

Clinical cancer research, 2014-12, Vol.20 (23), p.6163-6174

2014

Volltextzugriff (PDF)

Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography Era

International journal of radiation oncology, biology, physics, 2014-12, Vol.90 (5), p.1091-1098

2014

Volltextzugriff (PDF)

Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays

Fertility and sterility, 2017-02, Vol.107 (2), p.457-466.e9

2017

Volltextzugriff (PDF)

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

Gynecologic oncology, 2017-06, Vol.145 (3), p.519-525

2017

Volltextzugriff (PDF)

Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites

Frontiers in immunology, 2024-07, Vol.15, p.1379175

2024

Volltextzugriff (PDF)

Ovarian Cancer: Prevention, Detection, and Treatment of the Disease and its Recurrence. Molecular Mechanisms and Personalized Medicine Meeting Report

International journal of gynecological cancer, 2012-10, Vol.22 (8), p.S45-S57

2012

Volltextzugriff (PDF)

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells

Oncotarget, 2014-06, Vol.5 (12), p.4180-4194

2014

Volltextzugriff (PDF)

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

International journal of radiation oncology, biology, physics, 2019-05, Vol.104 (1), p.157-164

2019

Volltextzugriff (PDF)

Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

Human vaccines, 2009-10, Vol.5 (10), p.705-719

2009

Volltextzugriff (PDF)

Immunotherapy Advances for Epithelial Ovarian Cancer

Cancers, 2020-12, Vol.12 (12), p.3733

2020

Volltextzugriff (PDF)

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

NPJ precision oncology, 2021-12, Vol.5 (1), p.101-11, Article 101

2021

Volltextzugriff (PDF)

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

Cancer research (Chicago, Ill.), 2011-12, Vol.71 (24), p.7463-7470

2011

Volltextzugriff (PDF)

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

Oncoimmunology, 2023-12, Vol.12 (1), p.2198185-2198185

2023

Volltextzugriff (PDF)

Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse

International journal of radiation oncology, biology, physics, 2013-04, Vol.85 (5), p.1269-1274

2013

Volltextzugriff (PDF)

Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy

Cancers, 2022-11, Vol.14 (22), p.5647

2022

Volltextzugriff (PDF)

Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery

Gynecologic oncology, 2014-04, Vol.133 (1), p.78-82

2014

Volltextzugriff (PDF)

Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer

Epidemiology (Cambridge, Mass.), 2012-03, Vol.23 (2), p.311-319

2012

Volltextzugriff (PDF)

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location

PloS one, 2014-07, Vol.9 (7), p.e102409-e102409

2014

Volltextzugriff (PDF)

Web-Based Symptom Management for Women With Recurrent Ovarian Cancer: A Pilot Randomized Controlled Trial of the WRITE Symptoms Intervention

Journal of pain and symptom management, 2014-02, Vol.47 (2), p.218-230

2014

Volltextzugriff (PDF)

1 – 25 von 2.708

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(2.390)
Mit Volltextzugriff
(2.310)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The New England Journal Of Medicine
(60)
New England Journal Of Medicine/the new England Journal Of Medicine
(50)
Cancer Research
(36)
Gynecologic Oncology
(31)
Nature
(30)
Nature Communications
(29)
Pediatrics
(27)
Plos One
(26)
New England Journal Of Medicine
(24)
Brachytherapy
(22)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(21)

Menü

Weitere Dienste

Einstellungen

Cisplatin-induced immune modulation in ovarian cancer mouse models with distinct inflammation profiles

Diagnosis and Treatment of Ovarian Cancer

Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells

MRI-Guided High–Dose-Rate Intracavitary Brachytherapy for Treatment of Cervical Cancer: The University of Pittsburgh Experience

Prostaglandin E2 Leads to the Acquisition of DNMT3A-Dependent Tolerogenic Functions in Human Myeloid-Derived Suppressor Cells

Plasma MicroRNAs as Novel Biomarkers for Endometriosis and Endometriosis-Associated Ovarian Cancer

Complement pathway is frequently altered in endometriosis and endometriosis-associated ovarian cancer

Extended Field Intensity Modulated Radiation Therapy With Concomitant Boost for Lymph Node–Positive Cervical Cancer: Analysis of Regional Control and Recurrence Patterns in the Positron Emission Tomography/Computed Tomography Era

Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays

Surgical-pathological findings in type 1 and 2 endometrial cancer: An NRG Oncology/Gynecologic Oncology Group study on GOG-210 protocol

Characterization of latently infected EBV+ antibody-secreting B cells isolated from ovarian tumors and malignant ascites

Ovarian Cancer: Prevention, Detection, and Treatment of the Disease and its Recurrence. Molecular Mechanisms and Personalized Medicine Meeting Report

Novel combination of mitochondrial division inhibitor 1 (mdivi-1) and platinum agents produces synergistic pro-apoptotic effect in drug resistant tumor cells

Single-Institution Experience in 3D MRI-Based Brachytherapy for Cervical Cancer for 239 Women: Can Dose Overcome Poor Response?

Comparison of the immunogenicity and safety of Cervarix™ and Gardasil® human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18-45 years

Immunotherapy Advances for Epithelial Ovarian Cancer

High TGF-β signature predicts immunotherapy resistance in gynecologic cancer patients treated with immune checkpoint inhibition

PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment

Immunotherapy with IL12 and PD1/CTLA4 inhibition is effective in advanced ovarian cancer and associates with reversal of myeloid cell-induced immunosuppression

Preoperative Intensity Modulated Radiation Therapy and Chemotherapy for Locally Advanced Vulvar Carcinoma: Analysis of Pattern of Relapse

Longitudinal Modulation of Loco-Regional Immunity in Ovarian Cancer Patients Receiving Intraperitoneal Chemotherapy

Hormone receptor expression patterns in the endometrium of asymptomatic morbidly obese women before and after bariatric surgery

Aspirin, Nonaspirin Nonsteroidal Anti-inflammatory Drugs, or Acetaminophen and Risk of Ovarian Cancer

MUC1 positive, Kras and Pten driven mouse gynecologic tumors replicate human tumors and vary in survival and nuclear grade based on anatomical location

Web-Based Symptom Management for Women With Recurrent Ovarian Cancer: A Pilot Randomized Controlled Trial of the WRITE Symptoms Intervention

Suchergebnisse filtern